CDEK
← All organizations

Novus Pharma

For profit

Also known as: Anelixis Therapeutics, Inc. | Anelixis Therapeutics, LLC | Novus Therapeutics, Inc | Tokai Pharmaceuticals | Tokai Pharmaceuticals, Inc. | ZHEJIANG NOVUS PHARM

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2009

First marketed drug

Jan 20, 2023

Last known activity

Jan 20, 2023

Timeline

2000s

  1. Jun 1, 2004

    Novus Pharma— Founded

2010s

  1. May 10, 2017

    Otic Pharma— Acquired

2020s

  1. Jan 20, 2023

    vancomycin— Marketing Organization

  2. Jan 20, 2023

    vancomycin— NDA Secondary Org

Drugs by trial phase (8 distinct, 13 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 2 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (12)

Details

Founded
Boston, MA, US Jun 1, 2004
Last known activity
Jan 20, 2023

Notes

--- Pre-folding founded info: 2017-05-10 Irvine CA US https://www.prnewswire.com/news-releases/otic-pharma-completes-merger-with-tokai-pharmaceuticals-300454911.html ---